[ad_1]
EAST RUTHERFORD, N.J., Oct. 17, 2024 /PRNewswire/ — Cambrex, a prominent world oath construction and production group (CDMO), lately introduced that their balance reserve trade, Q1 Clinical, has opened a fresh cGMP facility in Durham, North Carolina, increasing its capability for environmentally managed balance reserve products and services to the pharmaceutical, scientific tool and existence sciences industries in North The us.
Strategically situated within the Analysis Triangle Terrain area, the fresh state of the art temperature-controlled and monitored reserve facility supplies 7 ICH balance chambers, overlaying a area of statuses together with 2-8°C, 25°C/60percentRH, 30°C/65percentRH, 30°C/75percentRH, and 40°C/75percentRH, in addition to each -20°C and ultra-low (-70°C/-80°C) reserve statuses. The power’s Analysis Triangle Terrain (RTP) location in North Carolina will lend identical age and nearest age supply throughout the US.
Tom Loewald, Cambrex CEO, said, “After acquiring Q1 Scientific in 2022, we have strategically expanded our footprint to best serve our clients worldwide. This first North American facility opening marks an important milestone in the growth of Q1 Scientific.”
Q1 Clinical’s enlargement enhances its present amenities in Waterford, Eire and Liège, Belgium, and is co-located inside Cambrex’s present analytical products and services website online in Durham.
Stephen Delaney, Managing Director of Q1 Clinical, added, “With the capabilities and expertise co-located in Durham, we can now deliver services beyond stability storage, such as stability testing and other analytical services for clinical and commercial products.”
Cambrex continues to increase its functions and capability throughout its North American and Eu community to fulfill the rising call for for outsourced drug construction and production products and services.
About Cambrex
Cambrex is a prominent world oath construction and production group (CDMO) that gives drug substance construction and production throughout all the drug lifecycle, in addition to complete analytical and IND enabling products and services.
With over 40 years of enjoy and a staff of two,000 mavens servicing world shoppers from North The us and Europe, Cambrex trade in a area of specialised drug substance applied sciences and functions, together with steady wave, managed components, solid-state science, subject matter characterization, and extremely potent APIs.
About Q1 Clinical, a Cambrex corporate
Q1 Clinical, a Cambrex Corporate, is a prominent supplier of environmentally managed balance reserve products and services for the pharmaceutical, scientific tool and existence sciences industries. With a decade of experience, Q1 Clinical safeguards vital breakthroughs and life-changing inventions at state of the art amenities in Eire and Belgium. By using Q1 Clinical’s products and services, firms can boost up the advent of fresh medication to the marketplace generation fending off the expense of establishing and tracking their very own reserve chambers. In June 2022, Q1 Clinical was once bought Cambrex.
Emblem – https://mma.prnewswire.com/media/2236065/Cambrex_logo.jpg
Emblem – https://mma.prnewswire.com/media/1830431/Q1_Scientific_Cambrex_Logo.jpg
WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+
Newsrooms &
Influencers
9k+
Virtual Media
Retailers
270k+
Reporters
Opted In
[ad_2]
Source link
